## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -1.5% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($63.50)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Sands China Celebrates 10th Anniversary of Local SME Supplier Support Programme and Hosts Supplier Excellence Awards**
- Source: PR Newswire | 20251209T130819 | Bullish | Relevance: 99%
-  Sands China celebrated the 10th anniversary of its Local Small, Medium and Micro Suppliers Support Programme with an event at The Londoner Macao, including the launch of a commemorative booklet. The celebration also featured the 2025 Sands Supplier Excellence Awards and a networking session for local businesses. This initiative, co-launched with the Macao Chamber of Commerce in 2015, aims to support local SMEs and has generated MOP 119.4 billion in procurement, with 83% local sourcing.

**2. Las Vegas Sands Stock: Is LVS Outperforming the Consumer Discretionary Sector?**
- Source: Yahoo Finance | 20251209T110818 | Bullish | Relevance: 99%
-  Las Vegas Sands Corp. (LVS) has significantly outperformed the Consumer Discretionary sector, as evidenced by its 24.8% gain over the past three months compared to the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) which marginally declined. This outperformance extends to longer terms, with LVS up 24.3% over the past 52 weeks and 66.8% over the past six months, driven by strong Q3 2025 results that beat analysts' expectations. Wall Street analysts are moderately bullish on LVS, giving it a "Moderate Buy" consensus rating.

**3. L2 Asset Management LLC Purchases 16,815 Shares of Las Vegas Sands Corp. $LVS**
- Source: MarketBeat | 20251208T122925 | Neutral | Relevance: 98%
-  L2 Asset Management LLC increased its stake in Las Vegas Sands Corp. (NYSE:LVS) by 42.8% during the second quarter, now owning 56,128 shares valued at approximately $2.44 million. This comes despite significant insider selling activity, with executives selling over 2.7 million shares totaling about $168 million in the last 90 days. Las Vegas Sands recently reported strong quarterly earnings, beating estimates with $0.78 EPS and $3.33 billion in revenue, and analysts maintain a "Moderate Buy" rating with an average target price of $65.60.

**4. Barclays Sticks to Their Buy Rating for Las Vegas Sands (LVS)**
- Source: The Globe and Mail | 20251206T150819 | Neutral | Relevance: 98%
-  Barclays analyst Brandt Montour has reiterated a Buy rating for Las Vegas Sands (LVS) with a $62.00 price target. This re-affirmation comes despite recent insider selling activity, highlighting the company's strong financial performance with growing quarterly revenue and net profit. Other analysts, including Argus Research, also maintain a "Buy" rating, while Wells Fargo initiated coverage with a "Hold" rating.

**5. Pres Dumont Sells 135,603 ($9.2M) Of Las Vegas Sands Corp [LVS]**
- Source: TradingView | 20251206T110825 | Neutral | Relevance: 98%
-  Patrick Dumont, President of Las Vegas Sands Corp (LVS), filed a Form 4 detailing an exercise and sale of company shares. On December 3, 2025, Dumont exercised 135,603 shares at $52.53 each, totaling $7,123,226, and simultaneously sold the same number of shares for $67.97 each, amounting to $9,216,258. Following these transactions, Dumont's direct holdings in LVS are 446,608 shares.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $68 | $67 | +1% |
| 2025-12-01 | Argus Research | $80 | $65 | +23% |
| 2025-11-18 | Wells Fargo | $66 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-18 | Wells Fargo | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($13.25M) |
| Sells | 12 ($64.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.1% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $65M sold (12 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.86 indicates undervaluation relative to growth. Forward P/E 21.1x stretched relative to 10% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (2 raises, avg +12%). Insider selling cluster ($64.9M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $46.0B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.86 |
| Forward P/E | 21.1 |
| Current P/E | 23.1 |
| YoY Growth | 9.6% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 0.7% to -1.5% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.46% (CS: 41) | Neutral |
| RSI_14 | 61.4 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.129x | Above |
| vs SMA200 | 1.375x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $67.08
- **Stop Loss:** $63.50 (5.3% risk)
- **Target:** $70.66 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 139
- **Position Value:** $9,324.12
- **Portfolio %:** 9.32%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*